Here are three value stocks to buy for the second half of 2021. With such a low valuation relative to its peers, you might think that AbbVie would be struggling. The company's revenue grew 51% year over year in the first quarter of 2021.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting